EHC
Encompass Health Corporation · Healthcare · Medical - Care Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | -3 | 69.23M | $6.99B | +2 | −6 |
| Q1 2026 | 138 | +3 | 68.76M | $6.68B | +9 | −7 |
| Q4 2025 | 136 | -2 | 75.50M | $8.01B | +1 | −2 |
| Q3 2025 | 24 | +2 | 41.27M | $5.24B | +2 | −1 |
| Q2 2025 | 20 | +2 | 37.20M | $4.56B | +2 | n/a |
| Q1 2025 | 15 | 0 | 14.75M | $1.49B | n/a | n/a |
| Q4 2024 | 15 | 0 | 14.46M | $1.34B | +1 | −1 |
| Q3 2024 | 14 | +3 | 13.62M | $1.32B | +3 | n/a |
| Q2 2024 | 11 | n/a | 14.78M | $1.27B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.89M | n/a | $591.30M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | Geode Capital Management ✦ (passive) | 1.65M | n/a | $141.86M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 1.54M | n/a | $131.81M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 1.14M | n/a | $98.12M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 1.14M | n/a | $97.68M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 872.19K | n/a | $74.83M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 790.46K | n/a | $67.81M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 455.43K | n/a | $39.07M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 207.20K | n/a | $17.78M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Bridgewater Associates ✦ | 57.68K | n/a | $4.95M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 33.97K | n/a | $2.91M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 577 holders, 95.06M shares, $8.15B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.86K sh · $588,255
Officer · 5.21K sh · $630,166
Officer · 18.87K sh · $2.37M
Officer, Director · 1.58K sh · $199,049
Officer · 8.91K sh · $1.12M
Officer, Director · 171.57K sh · $21.53M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology